The 3D Urology and Prostate Clinics introduce their groundbreaking 3D Prostate Cancer Targeted Treatment, offering innovative and effective solutions...
Vous n'êtes pas connecté
MONDAY, July 8, 2024 -- In a trial involving patients with therapy-refractory cancer treated with approved targeted or immunotherapies, matched to their tumor molecular profile but outside their registered indications, those for whom a waiver was...
The 3D Urology and Prostate Clinics introduce their groundbreaking 3D Prostate Cancer Targeted Treatment, offering innovative and effective solutions...
Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers
Exosome-based therapy targets squamous cell carcinomas that are drug-resistant and offers new hope for patients with drug-resistant cancers
Illumina's cancer biomarker test, TSO Comprehensive, gets approved by the FDA for use as CDx to match patients with targeted therapies.
The first two blood cancer patients in a US-based trial, who had suffered relapses despite having treatment, have now been in remission for up to 120...
Patients born with genetic blindness experienced significant visual improvements after a single treatment with gene therapy developed at the...
Patients born with genetic blindness experienced significant visual improvements after a single treatment with gene therapy developed at the...
After a single gene therapy treatment, patients with genetic blindness experienced new visual moments.
After a single gene therapy treatment, patients with genetic blindness experienced new visual moments.
Breakthrough in triple-negative breast cancer diagnosis: New test improves early detection, offering better outcomes and personalized treatment...